Trials / Conditions / Primary Mitochondrial Myopathy
Primary Mitochondrial Myopathy
5 registered clinical trials studyying Primary Mitochondrial Myopathy.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | An Open Label, Long Term Safety Study of REN001 in Primary Mitochondrial Myopathy Patients (Stride Ahead) NCT05267574 | Reneo Pharma Ltd | Phase 2 / Phase 3 |
| Terminated | A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial Myopathy NCT04641962 | Astellas Pharma Inc | Phase 2 |
| Completed | An Efficacy and Safety Study of 24 Week Treatment With Mavodelpar (REN001) in Primary Mitochondrial Myopathy P NCT04535609 | Reneo Pharma Ltd | Phase 2 |
| Terminated | A Study of the Safety of REN001 in Patients With Primary Mitochondrial Myopathy NCT03862846 | Reneo Pharma Ltd | Phase 1 |
| Terminated | A Trial to Evaluate Safety and Efficacy of Elamipretide Primary Mitochondrial Myopathy Followed by Open-Label NCT03323749 | Stealth BioTherapeutics Inc. | Phase 3 |